identified that OXCT1, an enzyme catalyzing ketone body oxidation, can act as a succinyltransferase, catalyzing the succinylation of the tumor suppressor protein LACTB at K284
Insurance companies treat semaglutide differently based on whether its prescribed for type 2 diabetes, another issue, or weight management
Full text Jamilian H, Jamilian M, Samimi M, Afshar Ebrahimi F, Rahimi M, Bahmani F, Aghababayan S, Kouhi M, Shahabbaspour S, Asemi Z
Recently, two novel therapeutic classes have emerged: sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists
IgBLAST: an immunoglobulin variable domain sequence analysis tool
To continue, please complete the security check below to verify you are human.